Prostate Cancer ‘Rosetta Stone’ Maps Mutations for Treatable Defects
Prostate Cancer ‘Rosetta Stone’ Maps Mutations for Treatable Defects – A genetic study described by researchers as the Rosetta stone of prostate cancer could provide hope for men with advanced forms of the disease.
British and US scientists who drew up the first comprehensive map of genetic mutations linked to different strains of prostate cancer found that almost 90% of the men whose DNA they studied carried potentially treatable defects. They also found that 8% of the men had genetic defects that predisposed them to prostate cancer, suggesting that it would help to screen people whi have a family history of the cancer.
The findings could lead to a range of personalized medicines that target specific gene defects, some of which are already in use or undergoing trials. They also learned that 8% of the men were born with genetic faults that predisposed them to prostate cancer, strengthening the case for screening people with a family history of the disease.
Category: News Videos, Videos
